Clinical Trials Directory

Trials / Completed

CompletedNCT02856139

Appearance of Far Peripheral Retina in Normal Eyes by Ultra-widefield Fluorescein Angiography

The Director of the Fundus Center of Zhongshan Ophthalmic Center

Status
Completed
Phase
Study type
Observational
Enrollment
61 (actual)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
70 Years
Healthy volunteers
Not accepted

Summary

PURPOSE: To characterize the appearance of the far peripheral retina of normal eyes using ultra-widefield fluorescein angiography (UWFA). DESIGN: Prospective observational case series. METHODS: This study enrolled normal eyes with best corrected visual acuity ≥ 20/20, refractive error \< 3.00D, and without visible retinal pathologic changes under a slit lamp-based condensing lens. The far peripheral retina was detected by UWFA. Ciliary body thickness (CBT) at 3 mm (CBT1) and 2 mm (CBT2) posterior to the scleral spur was measured by ultrasound biomicroscopy.

Detailed description

PURPOSE: To characterize the appearance of the far peripheral retina of normal eyes using ultra-widefield fluorescein angiography (UWFA). DESIGN: Prospective observational case series. METHODS: This study enrolled normal eyes with best corrected visual acuity ≥ 20/20, refractive error \< 3.00D, and without visible retinal pathologic changes under a slit lamp-based condensing lens. Demographic and clinical data such as age, sex, and reasons for undergoing FA were collected. The far peripheral retina was detected by UWFA. The fundal fields obtained using the Heidelberg ultra-widefield lens in a single shot and in montage images were compared with those acquired using the Heidelberg conventional 55° lens. The signs at the peripheral retina detected by UWFA were described and grouped. Ciliary body thickness (CBT) at 3 mm (CBT1) and 2 mm (CBT2) posterior to the scleral spur was measured by ultrasound biomicroscopy.

Conditions

Timeline

Start date
2014-11-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2016-08-04
Last updated
2016-08-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02856139. Inclusion in this directory is not an endorsement.